{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:24:00Z","timestamp":1780104240911,"version":"3.54.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ccm.2023.06.008","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T16:12:20Z","timestamp":1692029540000},"page":"847-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cystic Fibrosis-Related Nontuberculous Mycobacterial Pulmonary Disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Timothy","family":"Baird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ccm.2023.06.008_bib1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","article-title":"Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcf.2009.12.001","article-title":"Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis","volume":"9","author":"Esther","year":"2010","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcf.2014.08.002","article-title":"Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia","volume":"14","author":"Qvist","year":"2015","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcf.2014.05.008","article-title":"Increasing nontuberculous mycobacteria infection in cystic fibrosis","volume":"14","author":"Bar-On","year":"2015","journal-title":"J\u00a0Cyst Fibros"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0042-1759883","article-title":"Nontuberculous mycobacteria in cystic fibrosis in the era of cystic fibrosis Transmembrane Regulator modulators","volume":"44","author":"Burke","year":"2023","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ccm.2022.06.010","article-title":"Nontuberculous mycobacterial infections in cystic fibrosis","volume":"43","author":"Martiniano","year":"2022","journal-title":"Clin Chest Med"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.008_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1513\/AnnalsATS.201709-727OC","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial sputum positivity in patients with cystic fibrosis in the United States, 2010-2014","volume":"15","author":"Adjemian","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.008_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcf.2019.08.006","article-title":"Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry","volume":"19","author":"Hatziagorou","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.008_bib9","first-page":"731","article-title":"Epidemiology of nontuberculous mycobacteria infection in children and young people with cystic fibrosis: analysis of UK cystic fibrosis registry","volume":"68","author":"Gardner","year":"2019","journal-title":"Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.008_bib10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1513\/AnnalsATS.201404-184OC","article-title":"Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population","volume":"11","author":"Prevots","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.008_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1164\/rccm.202005-1520LE","article-title":"Clonally related viable nontuberculous mycobacteria in gastric Juice and sputum in people with cystic fibrosis","volume":"202","author":"Ward","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcf.2012.06.009","article-title":"Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations","volume":"12","author":"Catherinot","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.008_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/archdischild-2021-322177","article-title":"Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study","volume":"107","author":"Saint","year":"2022","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.008_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jcf.2016.03.002","article-title":"Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF)","volume":"15","author":"Viviani","year":"2016","journal-title":"J\u00a0Cyst Fibros"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.008_bib16","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/ppul.24913","article-title":"Risk factors for nontuberculous mycobacterial isolation in patients with cystic fibrosis: a meta-analysis","volume":"55","author":"Reynaud","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib17","doi-asserted-by":"crossref","first-page":"00578","DOI":"10.1183\/23120541.00578-2020","article-title":"Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection","volume":"7","author":"Caverly","year":"2021","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib18","doi-asserted-by":"crossref","first-page":"e01217","DOI":"10.1128\/mBio.01217-20","article-title":"Same Game, different Players: emerging pathogens of the CF lung","volume":"12","author":"Gannon","year":"2021","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.008_bib19","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1172\/JCI46095","article-title":"Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection","volume":"121","author":"Renna","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.008_bib20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1164\/rccm.201307-1200OC","article-title":"Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis","volume":"188","author":"Binder","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.008_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1513\/AnnalsATS.201801-012OC","article-title":"Chronic azithromycin Use in cystic fibrosis and risk of treatment-Emergent respiratory pathogens","volume":"15","author":"Cogen","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib22","doi-asserted-by":"crossref","first-page":"00724","DOI":"10.1183\/23120541.00724-2021","article-title":"CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011-2018","volume":"8","author":"Ricotta","year":"2022","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijmyco.2015.03.002","article-title":"Review: environmental mycobacteria as a cause of human infection","volume":"4","author":"Halstrom","year":"2015","journal-title":"Int J Mycobacteriol"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.008_bib24","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/ajrccm.185.2.231","article-title":"Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center","volume":"185","author":"Aitken","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"9877","key":"10.1016\/j.ccm.2023.06.008_bib26","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(13)60632-7","article-title":"Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study","volume":"381","author":"Bryant","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.008_bib27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.06.008_bib28","doi-asserted-by":"crossref","first-page":"139796","DOI":"10.1016\/j.scitotenv.2020.139796","article-title":"Influence of climate variables on the rising incidence of nontuberculous mycobacterial (NTM) infections in Queensland, Australia 2001-2016","volume":"740","author":"Thomson","year":"2020","journal-title":"Sci Total Environ"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.008_bib29","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1128\/JCM.00899-13","article-title":"Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM","volume":"51","author":"Thomson","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6313","key":"10.1016\/j.ccm.2023.06.008_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.aaf8156","article-title":"Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium","volume":"354","author":"Bryant","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ccm.2023.06.008_bib31","article-title":"Gastroesophageal reflux disease increases susceptibility to nontuberculous mycobacterial pulmonary disease","author":"Kim","year":"2022","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.008_bib32","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1164\/rccm.202108-1911OC","article-title":"Investigating nontuberculous mycobacteria transmission at the Colorado adult cystic fibrosis program","volume":"205","author":"Gross","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib33","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1080\/21505594.2021.1959808","article-title":"Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients","volume":"12","author":"Lewin","year":"2021","journal-title":"Virulence"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.008_bib34","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1513\/AnnalsATS.202009-1214OC","article-title":"Population Genomics of Mycobacterium abscessus from U.S. Cystic fibrosis care centers","volume":"18","author":"Davidson","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib35","doi-asserted-by":"crossref","first-page":"1602525","DOI":"10.1183\/13993003.02525-2016","article-title":"Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy","volume":"50","author":"Tortoli","year":"2017","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.008_bib36","doi-asserted-by":"crossref","first-page":"e0261628","DOI":"10.1371\/journal.pone.0261628","article-title":"Healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (HALT NTM) study: Rationale and study design","volume":"16","author":"Gross","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib38","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.008_bib39","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00330-016-4286-6","article-title":"Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest","volume":"26","author":"Kwak","year":"2016","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.008_bib40","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/microorganisms9081597","article-title":"Decontamination strategies used for AFB culture significantly reduce the viability of Mycobacterium abscessus complex in sputum samples from patients with cystic fibrosis","volume":"9","author":"Stephenson","year":"2021","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01519-18","article-title":"Performance of RGM medium for isolation of nontuberculous mycobacteria from respiratory Specimens from non-cystic fibrosis patients","volume":"57","author":"Rotcheewaphan","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ccm.2023.06.008_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jctube.2018.07.003","article-title":"Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patients in Belgium","volume":"13","author":"Scohy","year":"2018","journal-title":"J\u00a0Clin Tuberc Other Mycobact Dis"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.008_bib43","doi-asserted-by":"crossref","first-page":"e0021722","DOI":"10.1128\/jcm.00217-22","article-title":"Evaluation of MALDI Biotyper mycobacteria Library for identification of nontuberculous mycobacteria","volume":"60","author":"Toney","year":"2022","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib44","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001349","article-title":"Rapid macrolide and amikacin resistance testing for Mycobacterium abscessus in people with cystic fibrosis","volume":"70","author":"Bordin","year":"2021","journal-title":"J\u00a0Med Microbiol"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jcf.2018.11.011","article-title":"Antibody response against Mycobacterium avium complex in cystic fibrosis patients measured by a novel IgG ELISA test","volume":"18","author":"Ravnholt","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.008_bib46","doi-asserted-by":"crossref","first-page":"e0019222","DOI":"10.1128\/spectrum.00192-22","article-title":"IgA Serological response for the diagnosis of Mycobacterium abscessus infections in patients with cystic fibrosis","volume":"10","author":"Le Moigne","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2023.06.008_bib47","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","article-title":"US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jcf.2020.02.013","article-title":"Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers","volume":"19","author":"Low","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2023.06.008_bib49","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"issue":"163","key":"10.1016\/j.ccm.2023.06.008_bib50","doi-asserted-by":"crossref","first-page":"210212","DOI":"10.1183\/16000617.0212-2021","article-title":"Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments","volume":"31","author":"Kumar","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.008_bib51","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A Prospective, Open-Label, Randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"S44","key":"10.1016\/j.ccm.2023.06.008_bib52","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/ppul.23505","article-title":"Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis","volume":"51","author":"Jordan","year":"2016","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ppul.24604","article-title":"Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis","volume":"55","author":"Martiniano","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2021.07.035","article-title":"Treatment of Mycobacterium abscessus pulmonary disease","volume":"161","author":"Griffith","year":"2022","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.008_bib55","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/cells11071243","article-title":"CFTR modulator therapies: potential impact on airway infections in cystic fibrosis","volume":"11","author":"Saluzzo","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17425255.2021.1836157","article-title":"The pharmacokinetics of antibiotics in cystic fibrosis","volume":"17","author":"Akkerman-Nijland","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.008_bib57","doi-asserted-by":"crossref","first-page":"106381","DOI":"10.1016\/j.ijantimicag.2021.106381","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review","volume":"58","author":"Castagnola","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.008_bib58","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcf.2021.04.011","article-title":"Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosis","volume":"20","author":"Martiniano","year":"2021","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.ccm.2023.06.008_bib59","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1002\/ppul.24939","article-title":"Novel therapies for treatment of resistant and refractory nontuberculous mycobacterial infections in patients with cystic fibrosis","volume":"56","author":"Laudone","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01798-16","article-title":"In\u00a0Vitro susceptibility testing of Bedaquiline against Mycobacterium avium complex","volume":"61","author":"Brown-Elliott","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib61","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.14-2764","article-title":"Preliminary results of Bedaquiline as Salvage therapy for patients with nontuberculous mycobacterial lung disease","volume":"148","author":"Philley","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.008_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01947-20","article-title":"In\u00a0vitro susceptibility testing of omadacycline against nontuberculous mycobacteria","volume":"65","author":"Brown-Elliott","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.008_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02522-18","article-title":"In\u00a0Vitro Activities of omadacycline against rapidly growing mycobacteria","volume":"63","author":"Shoen","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.008_bib64","doi-asserted-by":"crossref","first-page":"ofaa415","DOI":"10.1093\/ofid\/ofaa415","article-title":"Omadacycline for the treatment of Mycobacterium abscessus disease: a case series","volume":"7","author":"Pearson","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib65","doi-asserted-by":"crossref","first-page":"ofab002","DOI":"10.1093\/ofid\/ofab002","article-title":"Preliminary, real-world, multicenter experience with omadacycline for Mycobacterium abscessus infections","volume":"8","author":"Morrisette","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib66","doi-asserted-by":"crossref","first-page":"ofab093","DOI":"10.1093\/ofid\/ofab093","article-title":"Tedizolid vs Linezolid for the treatment of nontuberculous mycobacteria infections in Solid Organ transplant recipients","volume":"8","author":"Poon","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.008_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00470-19","article-title":"In\u00a0vitro activity of new Tetracycline Analogs omadacycline and Eravacycline against drug-resistant clinical isolates of Mycobacterium abscessus","volume":"63","author":"Kaushik","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib68","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jac\/dku510","article-title":"\u03b2-Lactamase inhibition by avibactam in Mycobacterium abscessus","volume":"70","author":"Dub\u00e9e","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib69","doi-asserted-by":"crossref","first-page":"e01915","DOI":"10.1128\/AAC.01915-18","article-title":"In\u00a0Vitro and intracellular activity of imipenem combined with tedizolid, rifabutin, and avibactam against Mycobacterium abscessus","volume":"63","author":"Le Run","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib70","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02545-20","article-title":"\u03b2-Lactam combinations that Exhibit Synergy against Mycobacteroides abscessus clinical isolates","volume":"65","author":"Story-Roller","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib71","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.jcf.2019.04.017","article-title":"Use of inhaled imipenem\/cilastatin in pediatric patients with cystic fibrosis: a case series","volume":"18","author":"Jones","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.008_bib72","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/jac\/dkaa110","article-title":"Inhaled tigecycline is effective against Mycobacterium abscessus in\u00a0vitro and in\u00a0vivo","volume":"75","author":"Pearce","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.008_bib73","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jcf.2019.05.013","article-title":"Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections","volume":"18","author":"Banaschewski","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib74","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/INF.0000000000001780","article-title":"Compassionate nitric oxide Adjuvant treatment of persistent Mycobacterium infection in cystic fibrosis patients","volume":"37","author":"Yaacoby-Bianu","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jcf.2019.05.002","article-title":"Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection","volume":"19","author":"Bentur","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.008_bib76","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1183\/09031936.04.00036704","article-title":"Inhaled IFN-gamma for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-gamma deficiency","volume":"24","author":"Hallstrand","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.06.008_bib77","doi-asserted-by":"crossref","first-page":"1702127","DOI":"10.1183\/13993003.02127-2017","article-title":"Inhaled granulocyte-macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis","volume":"51","author":"Scott","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.008_bib78","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ccm.2023.06.008_bib79","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.cell.2022.04.024","article-title":"Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection","volume":"185","author":"Nick","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib80","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12890-018-0635-3","article-title":"NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice","volume":"18","author":"Tissot","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.008_bib81","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.transproceed.2019.02.028","article-title":"Outcomes in lung transplant recipients with Mycobacterium abscessus infection: a 15-year experience from a large Tertiary care center","volume":"51","author":"Hamad","year":"2019","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.008_bib82","doi-asserted-by":"crossref","first-page":"e13046","DOI":"10.1111\/tid.13046","article-title":"Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series","volume":"21","author":"Raats","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib83","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.transproceed.2012.02.035","article-title":"Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population","volume":"45","author":"Qvist","year":"2013","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.008_bib84","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S2213-2600(13)70162-0","article-title":"Respiratory infections in patients with cystic fibrosis undergoing lung transplantation","volume":"2","author":"Lobo","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.008_bib85","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.healun.2006.09.003","article-title":"Mycobacterium abscessus infections in lung transplant recipients: the international experience","volume":"25","author":"Chernenko","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.008_bib86","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1399-3062.2012.00753.x","article-title":"Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study","volume":"14","author":"Knoll","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.008_bib87","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/tid.12546","article-title":"Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation","volume":"18","author":"Shah","year":"2016","journal-title":"Transpl Infect Dis"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:16:06Z","timestamp":1759454166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523123000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0272523123000497"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2023.06.008","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic Fibrosis-Related Nontuberculous Mycobacterial Pulmonary Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2023.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}